Drug Type Small molecule drug |
Synonyms Betamethasone benzoate (USP), Uticort |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Drug Highest PhaseApproved |
First Approval Date US (28 Jun 1974), |
Regulation- |
Molecular FormulaC29H33FO6 |
InChIKeySOQJPQZCPBDOMF-YCUXZELOSA-N |
CAS Registry22298-29-9 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Adrenal Hyperplasia, Congenital | - | - | |
Ankylosing Spondylitis | - | - | |
Arthritis, Gouty | - | - | |
Asthma | - | - | |
Brain Edema | - | - | |
Colitis, Ulcerative | - | - | |
Dermatitis, Atopic | - | - | |
Dermatomyositis | - | - | |
Hypercalcemia | - | - | |
Juvenile Arthritis | - | - | |
Lupus Erythematosus, Discoid | - | - | |
Lymphoma | - | - | |
Mycosis Fungoides | - | - | |
Pemphigoid, Bullous | - | - | |
Polymyositis | - | - | |
Psoriasis | - | - | |
Rheumatoid Arthritis | - | - | |
Stevens-Johnson Syndrome | - | - | |
Systemic Lupus Erythematosus | - | - | |
Uveitis | - | - |